Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled, phase 3 study-Reference-Cited by-同舟云学术

Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled, phase 3 study

Published:2016-03 Issue:10022 Volume:387 Page:968-977
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Yao James C,Fazio Nicola,Singh Simron,Buzzoni Roberto,Carnaghi Carlo,Wolin Edward,Tomasek Jiri,Raderer Markus,Lahner Harald,Voi Maurizio,Pacaud Lida Bubuteishvili,Rouyrre Nicolas,Sachs Carolin,Valle Juan W,Fave Gianfranco Delle,Van Cutsem Eric,Tesselaar Margot,Shimada Yasuhiro,Oh Do-Youn,Strosberg Jonathan,Kulke Matthew H,Pavel Marianne E

Publisher

Elsevier BV

Subject

General Medicine

Reference20 articles.

1. One hundred years after “carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States;Yao;J Clin Oncol,2008

2. Prevalence of functional tumors in neuroendocrine carcinoma: an analysis from the NCCN NET database;Choti;J Clin Oncol,2012

3. Optimising therapeutic options for patients with advanced pancreatic neuroendocrine tumours;Yao;Eur Oncol Haematol,2012

4. Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group;Rinke;J Clin Oncol,2009

5. Lanreotide in metastatic enteropancreatic neuroendocrine tumors;Caplin;N Engl J Med,2014

Cited by 941 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular Targeting of the Phosphoinositide-3-Protein Kinase (PI3K) Pathway across Various Cancers;International Journal of Molecular Sciences;2024-02-06

2. Multimodal management of foregut neuroendocrine neoplasms;Best Practice & Research Clinical Gastroenterology;2024-02

3. Hepatic cytoreduction for lung and renal neuroendocrine tumor metastases;The American Journal of Surgery;2024-02

4. Visual and whole-body quantitative analyses of 68 Ga-DOTATATE PET/CT for prognosis of outcome after PRRT with 177Lu-DOTATATE;Annals of Nuclear Medicine;2024-01-22

5. Sequencing of Somatostatin-Receptor–Based Therapies in Neuroendocrine Tumor Patients;Journal of Nuclear Medicine;2024-01-18